Fiera Capital Corp decreased its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 21.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 132,877 shares of the conglomerate’s stock after selling 37,240 shares during the quarter. Fiera Capital Corp’s holdings in Danaher were worth $27,240,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of DHR. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares in the last quarter. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the fourth quarter worth about $27,000. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the first quarter valued at approximately $31,000. Finally, Hurley Capital LLC acquired a new stake in Danaher during the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insiders Place Their Bets
In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.20% of the stock is owned by company insiders.
Analysts Set New Price Targets
Check Out Our Latest Report on Danaher
Danaher Stock Performance
Shares of DHR stock opened at $206.83 on Wednesday. The firm has a market capitalization of $148.10 billion, a price-to-earnings ratio of 44.01, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The business has a 50 day simple moving average of $196.69 and a 200 day simple moving average of $203.24.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.72 earnings per share. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, July 25th. Shareholders of record on Friday, June 27th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. Danaher’s dividend payout ratio (DPR) is 27.23%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Should Investors Lock Arms With Buffett and Dive Into POOL Stock?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2
- Where to Find Earnings Call Transcripts
- Analysts Are Upgrading These 3 Massive AI Stocks After Earnings
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.